Medigen Biotechnology Corp. (TPEX:3176)
Taiwan · Delayed Price · Currency is TWD 38.20
+0.60 (1.60%)
Jul 9, 2026, 1:30 PM CST
Medigen Biotechnology Market Cap
Medigen Biotechnology has a market cap or net worth of 5.32 billion as of July 9, 2026. Its market cap has increased by 24.23% in one year.
Market Cap
5.32B
Enterprise Value
7.41B
Revenue
1.34B
Ranking
n/a
PE Ratio
n/a
Stock Price
38.20
Market Cap Chart
Since November 3, 2004, Medigen Biotechnology's market cap has increased from 684.56M to 5.32B, an increase of 677.36%. That is a compound annual growth rate of 9.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 5.32B | 17.90% |
| Dec 31, 2025 | 4.51B | - |
| Dec 31, 2024 | 4.51B | -27.70% |
| Dec 29, 2023 | 6.24B | 33.24% |
| Dec 30, 2022 | 4.69B | -41.43% |
| Dec 30, 2021 | 8.00B | -2.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sinphar Pharmaceutical | 6.44B |
| AnnJi Pharmaceutical | 5.94B |
| Mycenax Biotech | 5.50B |
| TWi Biotechnology | 5.46B |
| UnicoCell Biomed | 5.18B |
| Sinew Pharma | 4.96B |
| Steminent Biotherapeutics | 4.93B |
| Pharmosa Biopharm | 4.91B |